Gradient Investments LLC Myriad Genetics Inc Transaction History

Gradient Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 06, 2020	SELL	$11.25 - $14.75 $4,725 - $6,195	-420 Closed	0 $0
Q1 2020 Apr 07, 2020	SELL	$9.78 - $29.53 $1,955 - $5,906	-200 Reduced 32.26%	420 $6,000
Q3 2019 Oct 10, 2019	BUY	$22.08 - $47.08 $4,416 - $9,416	200 Added 47.62%	620 $18,000
Q4 2017 Feb 07, 2018	BUY	$28.45 - $37.14 $11,949 - $15,598	420	420 $14,000

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $947M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.